InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Altimmune, Inc.

ALT Clue Score41
United States Fiscal year ends December CIK 0001326190 Results filed 12 Aug 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

9
Insider
Date
Role
Action
Shares
Price
Amount
David Drutz
19 Aug 2024
Director
Sold after exercise indirect
8,184
$6.88
$56.31K
David Drutz
19 Aug 2024
Director
Sold after exercise indirect
7,827
$6.93
$54.24K
Wayne Pisano
22 Dec 2022
Director
Sold after exercise
20,000
$15.01
$300.27K
M Scot Roberts
5 Jul 2022
Chief Scientific Officer
Sold after exercise
10,182
$12.00
$122.18K
M Scot Roberts
1 Jul 2022
Chief Scientific Officer
Sold after exercise
26,982
$12.00
$323.78K
M Scot Roberts
29 Jun 2022
Chief Scientific Officer
Sold after exercise
5,462
$12.00
$65.55K
Diane Jorkasky
27 Jun 2022
Director
Sold after exercise
17,610
$11.75
$206.94K
M Scot Roberts
27 Jun 2022
Chief Scientific Officer
Sold after exercise
37,352
$12.00
$448.25K
Matthew Scott Harris
28 Feb 2022
Chief Medical Officer
Sold after exercise
30,000
$7.52
$225.60K
Show all 122 transactions →

What was left out

Form 4 filings counted 335
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 19
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 9
Sales at will 15
Transactions with no price 0
Shares from compensation/vesting 13,705,868
Sales filed before the plan box existed 14
History held since 7 May 2007